“agios-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More 08/04/17 National
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Just Four Months After Series A, Delinia Sells to Celgene For $300M 01/26/17 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More 12/06/16 National
Third Rock Gets $616M to Grow New Crop of Biotech Startups 10/31/16 Boston
Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs 10/17/16 New York
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug 09/07/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
Hear Lew Cantley, Others on Shaping NY Biotech on March 29 03/11/16 New York
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
Page 1 of 5 next page »